
Michael C. Miggins
Examiner (ID: 8774, Phone: (571)272-1494 , Office: P/1782 )
| Most Active Art Unit | 1782 |
| Art Unit(s) | 1753, 1794, 1782, 1772 |
| Total Applications | 2260 |
| Issued Applications | 1664 |
| Pending Applications | 216 |
| Abandoned Applications | 412 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19021311
[patent_doc_number] => 20240077482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => METHODS AND APPARATUSES FOR DETECTING RESPIRATORY INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/296982
[patent_app_country] => US
[patent_app_date] => 2023-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19784
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18296982
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/296982 | METHODS AND APPARATUSES FOR DETECTING RESPIRATORY INFECTIONS | Apr 5, 2023 | Pending |
Array
(
[id] => 18806897
[patent_doc_number] => 20230381230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => CHIMERIC ANTIGEN RECEPTOR WITH MODIFIED HINGE REGION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/050461
[patent_app_country] => US
[patent_app_date] => 2022-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10605
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18050461
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/050461 | CHIMERIC ANTIGEN RECEPTOR WITH MODIFIED HINGE REGION AND USES THEREOF | Oct 26, 2022 | Pending |
Array
(
[id] => 20562030
[patent_doc_number] => 12564620
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-03
[patent_title] => Treatment of gulf war illness
[patent_app_type] => utility
[patent_app_number] => 17/945993
[patent_app_country] => US
[patent_app_date] => 2022-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 37
[patent_no_of_words] => 7376
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17945993
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/945993 | Treatment of gulf war illness | Sep 14, 2022 | Issued |
Array
(
[id] => 19984242
[patent_doc_number] => 20250122464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-17
[patent_title] => MICROALGAE STRAIN HAVING EFFECT OF PROMOTING PLANT GROWTH AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/682032
[patent_app_country] => US
[patent_app_date] => 2022-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18682032
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/682032 | MICROALGAE STRAIN HAVING EFFECT OF PROMOTING PLANT GROWTH AND USE THEREOF | Aug 8, 2022 | Pending |
Array
(
[id] => 18168394
[patent_doc_number] => 20230035004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => THERAPEUTIC COMPOSITIONS CONTAINING BACTERIAL OUTER MEMBRANE VESICLES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/815729
[patent_app_country] => US
[patent_app_date] => 2022-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7544
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17815729
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/815729 | THERAPEUTIC COMPOSITIONS CONTAINING BACTERIAL OUTER MEMBRANE VESICLES AND USES THEREOF | Jul 27, 2022 | Pending |
Array
(
[id] => 19862657
[patent_doc_number] => 20250101443
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-27
[patent_title] => MICROORGANISM HAVING WEAKENED ACTIVITY OF LACI FAMILY DNA-BINDING TRANSCRIPTIONAL REGULATOR, AND L-GLUTAMIC ACID PRODUCTION METHOD USING SAME
[patent_app_type] => utility
[patent_app_number] => 18/291827
[patent_app_country] => US
[patent_app_date] => 2022-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9278
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18291827
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/291827 | MICROORGANISM HAVING WEAKENED ACTIVITY OF LACI FAMILY DNA-BINDING TRANSCRIPTIONAL REGULATOR, AND L-GLUTAMIC ACID PRODUCTION METHOD USING SAME | Jul 24, 2022 | Pending |
Array
(
[id] => 20220099
[patent_doc_number] => 20250283030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-11
[patent_title] => Biosynthesis of Phenylpropanoid Compounds
[patent_app_type] => utility
[patent_app_number] => 18/289895
[patent_app_country] => US
[patent_app_date] => 2022-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4911
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18289895
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/289895 | Biosynthesis of Phenylpropanoid Compounds | May 8, 2022 | Pending |
Array
(
[id] => 18274654
[patent_doc_number] => 11613585
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-28
[patent_title] => Nucleic acids encoding antagonistic CD40 monoclonal antibodies
[patent_app_type] => utility
[patent_app_number] => 17/561529
[patent_app_country] => US
[patent_app_date] => 2021-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 14701
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17561529
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/561529 | Nucleic acids encoding antagonistic CD40 monoclonal antibodies | Dec 22, 2021 | Issued |
Array
(
[id] => 18939845
[patent_doc_number] => 20240034984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-01
[patent_title] => CULTURE MEDIUM, METHOD FOR PRODUCING SAME, AND BACTERIAL CULTURE METHOD
[patent_app_type] => utility
[patent_app_number] => 18/258201
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18258201
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/258201 | CULTURE MEDIUM, METHOD FOR PRODUCING SAME, AND BACTERIAL CULTURE METHOD | Dec 16, 2021 | Abandoned |
Array
(
[id] => 18970383
[patent_doc_number] => 20240050475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => COMPOSITION COMPRISING AN ANTIBODY WHICH BINDS TO HUMAN PRDX4 PRESENT ON THE CELL SURFACE OF A TARGET CELL
[patent_app_type] => utility
[patent_app_number] => 18/266446
[patent_app_country] => US
[patent_app_date] => 2021-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24136
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18266446
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/266446 | COMPOSITION COMPRISING AN ANTIBODY WHICH BINDS TO HUMAN PRDX4 PRESENT ON THE CELL SURFACE OF A TARGET CELL | Dec 9, 2021 | Pending |
Array
(
[id] => 19001991
[patent_doc_number] => 20240066062
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => METHODS AND MATERIALS FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 18/266472
[patent_app_country] => US
[patent_app_date] => 2021-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28837
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 1
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18266472
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/266472 | METHODS AND MATERIALS FOR TREATING CANCER | Dec 9, 2021 | Pending |
Array
(
[id] => 17460331
[patent_doc_number] => 20220073636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L
[patent_app_type] => utility
[patent_app_number] => 17/522008
[patent_app_country] => US
[patent_app_date] => 2021-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30801
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17522008
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/522008 | ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L | Nov 8, 2021 | Abandoned |
Array
(
[id] => 19067203
[patent_doc_number] => 20240101629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => USE OF INTERLEUKIN-7 FOR THE TREATMENT OF CORONAVIRUS
[patent_app_type] => utility
[patent_app_number] => 18/251474
[patent_app_country] => US
[patent_app_date] => 2021-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35079
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18251474
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/251474 | USE OF INTERLEUKIN-7 FOR THE TREATMENT OF CORONAVIRUS | Nov 1, 2021 | Pending |
Array
(
[id] => 17867123
[patent_doc_number] => 20220289858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => ANTI-CD40 ANTIBODIES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/496476
[patent_app_country] => US
[patent_app_date] => 2021-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47526
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17496476
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/496476 | ANTI-CD40 ANTIBODIES AND USES THEREOF | Oct 6, 2021 | Abandoned |
Array
(
[id] => 17369963
[patent_doc_number] => 20220025015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => Methods, compositions and therapeutical vaccine for autoimmune diseases and allergy treatment
[patent_app_type] => utility
[patent_app_number] => 17/495639
[patent_app_country] => US
[patent_app_date] => 2021-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30534
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17495639
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/495639 | Methods, compositions and therapeutical vaccine for autoimmune diseases and allergy treatment | Oct 5, 2021 | Abandoned |
Array
(
[id] => 17369976
[patent_doc_number] => 20220025028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => Methods of Treating or Preventing Periodontitis and Diseases Associated with Periodontitis
[patent_app_type] => utility
[patent_app_number] => 17/493158
[patent_app_country] => US
[patent_app_date] => 2021-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14582
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17493158
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/493158 | Methods of Treating or Preventing Periodontitis and Diseases Associated with Periodontitis | Oct 3, 2021 | Abandoned |
Array
(
[id] => 18707582
[patent_doc_number] => 20230330159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => COMPOSITION FOR DIAGNOSIS OR TREATMENT OF INFLAMMATORY DISEASES, COMPRISING MICROORGANISM
[patent_app_type] => utility
[patent_app_number] => 18/028913
[patent_app_country] => US
[patent_app_date] => 2021-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19424
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18028913
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/028913 | COMPOSITION FOR DIAGNOSIS OR TREATMENT OF INFLAMMATORY DISEASES, COMPRISING MICROORGANISM | Sep 26, 2021 | Pending |
Array
(
[id] => 17342204
[patent_doc_number] => 20220008535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => METHODS AND COMPOSITIONS FOR THE TREATMENT AND/OR PREVENTION OF TYPE 1 DIABETES
[patent_app_type] => utility
[patent_app_number] => 17/466097
[patent_app_country] => US
[patent_app_date] => 2021-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17803
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17466097
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/466097 | METHODS AND COMPOSITIONS FOR THE TREATMENT AND/OR PREVENTION OF TYPE 1 DIABETES | Sep 2, 2021 | Abandoned |
Array
(
[id] => 17334664
[patent_doc_number] => 20220000995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => NOVEL COMBINATIONS FOR ANTIGEN BASED THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/458018
[patent_app_country] => US
[patent_app_date] => 2021-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30734
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17458018
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/458018 | NOVEL COMBINATIONS FOR ANTIGEN BASED THERAPY | Aug 25, 2021 | Abandoned |
Array
(
[id] => 17243477
[patent_doc_number] => 20210363220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => METHODS AND REAGENTS TO TREAT AUTOIMMUNE DISEASES AND ALLERGY
[patent_app_type] => utility
[patent_app_number] => 17/344932
[patent_app_country] => US
[patent_app_date] => 2021-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22789
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17344932
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/344932 | METHODS AND REAGENTS TO TREAT AUTOIMMUNE DISEASES AND ALLERGY | Jun 9, 2021 | Abandoned |